SCHEMBL4429627

SCHEMBL4429627

Cc1cc(-c2cc(C(N)=O)nn2Cc2ccccc2)ccc1Cl

nearest known ligand 0.55

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ MALT1 Q9UDY8 1/20 0.55
▸ MARS1 P56192 4/20 0.53
▸ CNR2 P34972 5/20 0.47
▸ CNR1 P21554 2/20 0.47
▸ PTGER1 P34995 2/20 0.47
▸ BRD4 O60885 1/20 0.45
▸ MGLL Q99685 2/20 0.43
▸ SLC16A3 O15427 2/20 0.43
▸ SLC16A1 P53985 1/20 0.43
▸ MCTS1 Q9ULC4 1/20 0.43
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ PPP1CA P62136 1/20 0.42
▸ PPARG P37231 1/20 0.42
▸ PPARD Q03181 1/20 0.42
▸ PPARA Q07869 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8313106 0.91 CNR2 (0.56) MALT1MARS1CNR2CNR1MGLL
SCHEMBL5902998 0.82 CNR2 (0.57) MALT1MARS1CNR2CNR1PPP1CA
SCHEMBL8364557 0.81 MALT1 (0.42) MALT1MARS1CNR2CNR1MGLL
SCHEMBL8369153 0.81 MARS1 (0.53) MALT1MARS1CNR2CNR1PPP1CA
SCHEMBL8366415 0.81 MARS1 (0.53) MALT1MARS1CNR2CNR1PPP1CA
Hydrochloric Acid SCHEMBL8369717 0.81 CNR2 (0.56) MALT1MARS1CNR2CNR1PPP1CA
SCHEMBL27739396 0.81 HDAC3 (0.44) MALT1MARS1CNR2BRD4SLC16A3
SCHEMBL5903036 0.80 CNR2 (0.59) MALT1MARS1CNR2CNR1MGLL
SCHEMBL8366452 0.79 RPA1 (0.50) MALT1MARS1CNR2CNR1MGLL
SCHEMBL8368115 0.78 RPA1 (0.55) MARS1CNR2CNR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2026798-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING CBX CANNABINOID RECEPTOR MODULATORS AND POTASSIUM CHANNEL MODULATORS Solvay Pharmaceuticals GmbH (DE) 2009-02-25 — — EP disclosed
WO-2007125048-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING CBX CANNABINOID RECEPTOR MODULATORS AND POTASSIUM CHANNEL MODULATORS SOLVAY PHARMACEUTICALS GMBH (DE) 2007-11-08 — — WO disclosed
Send feedback